Literature DB >> 24272840

In situ intestinal absorption of a poorly water-soluble drug from mixed micellar solutions of bile salt and lipolysis products in rats.

A T Serajuddin1, M Rosoff, A H Goldberg.   

Abstract

The role of a bile salt (sodium taurocholate) and lipolysis products (monoglyceride and fatty acid) in the intestinal absorption of a poorly water-soluble drug, diazepam, was investigated. Absorption rates and bioavailabilities were determined with the in situ rat gut technique of Doluisio et al. and analyzing the diazepam concentrations in the luminal solution, intestinal membrane, blood and lymph. The absorption rate constant of diazepam decreased with the increase in bile salt concentration. Thus, although the bile salt increased the solubility of diazepam, the net effect was a decrease in apparent diazepam absorption rate. On the other hand, the lipolysis products incorporated in the bile salt micelles increased the solubility of diazepam without affecting the absorption rate constant, and as a result the apparent absorption rate of diazepam increased. In addition, the solubilized diazepam was absorbed almost uniformly throughout the small intestine. The drug solubilized in mixed micelles of bile salt-lipolysis products was not absorbed through the lymphatic system along with the lipolysis products, rather it was absorbed directly into the blood. The possible mechanism of the effect of dietary fat in the absorption of drug is discussed.

Entities:  

Year:  1985        PMID: 24272840     DOI: 10.1023/A:1016312827680

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  20 in total

1.  THE FUNCTION OF BILE SALTS IN FAT ABSORPTION. THE SOLVENT PROPERTIES OF DILUTE MICELLAR SOLUTIONS OF CONJUGATED BILE SALTS.

Authors:  A F HOFMANN
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  The behavior and solubility of monoglycerides in dilute, micellar bile-salt solution.

Authors:  A F HOFMANN
Journal:  Biochim Biophys Acta       Date:  1963-06-18

3.  Biovailability of phenytoin in lipid containing dosage forms in rats.

Authors:  S Chakrabarti; F M Belpaire
Journal:  J Pharm Pharmacol       Date:  1978-05       Impact factor: 3.765

Review 4.  Role of the ileum in fat absorption.

Authors:  E E Wollaeger
Journal:  Mayo Clin Proc       Date:  1973-12       Impact factor: 7.616

5.  A simplified method of cannulating the intestinal lymphatic of the rat.

Authors:  A L Warshaw
Journal:  Gut       Date:  1972-01       Impact factor: 23.059

6.  Drug absorption. I. An in situ rat gut technique yielding realistic absorption rates.

Authors:  J T Doluisio; N F Billups; L W Dittert; E T Sugita; J V Swintosky
Journal:  J Pharm Sci       Date:  1969-10       Impact factor: 3.534

7.  Blood level distribution patterns of diazepam and its major metabolite in man.

Authors:  J A De Silva; B A Koechlin; G Bader
Journal:  J Pharm Sci       Date:  1966-07       Impact factor: 3.534

8.  Theoretical and experimental studies of transport of micelle-solubilized solutes.

Authors:  G E Amidon; W I Higuchi; N F Ho
Journal:  J Pharm Sci       Date:  1982-01       Impact factor: 3.534

9.  Absorption of cholesterol from a micellar solution: intestinal perfusion studies in man.

Authors:  W J Simmonds; A F Hofmann; E Theodor
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

10.  Partition of lipids between emulsified oil and micellar phases of glyceride-bile salt dispersions.

Authors:  B Borgström
Journal:  J Lipid Res       Date:  1967-11       Impact factor: 5.922

View more
  2 in total

1.  In vitro model for ciclosporin intestinal absorption in lipid vehicles.

Authors:  J P Reymond; H Sucker
Journal:  Pharm Res       Date:  1988-10       Impact factor: 4.200

2.  Pancreatic lipase-catalyzed hydrolysis of esters of hydroxymethyl phenytoin dissolved in various metabolizable vehicles, dispersed in micellar systems, and in aqueous suspensions.

Authors:  F J Alvarez; V J Stella
Journal:  Pharm Res       Date:  1989-07       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.